A method of treating skin is disclosed. The method can include topically applying to a peron's skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei, and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.

The present invention generally relates to the field of skin care. More particularly, the invention relates to a cosmetic or therapeutic skin care composition comprising live bacteria of at least one Cutibacterium acnes (C. acnes) strain in combination with a filler that specifically supports their viability during storage and/or their ability to replicate after application to the skin. Preferably, the cosmetic or therapeutic skin care composition comprises bacteria of at least one C. acnes strain selected from the group consisting of D1, A5, C1, C3, H1, H2, H3, K1, K2, K4, K6, K8, K9, L1, and F4. The invention also provides a method for treating or preventing acne by applying the skin care composition of the invention to a skin area in need of treatment. The invention also relates to the use of a skin care composition of the invention for treating or preventing acne.

Reshaping compositions, methods or processes, and kits-of-part reshape keratin fibers. The reshaping composition is a non-reducing, non-oxidizing composition for keratin fibers having a pH in the range of 7 to 12, and comprising a) one or more organic alkalizing agents having a pK.sub.a of less than 9.0, b) one or more lipophilic compounds being liquid at 25° C. and atmospheric pressure, at a total concentration in the range of 10% to 80% by weight, calculated to a total weight of the composition, c) one or more surfactants, and d) one or more thickening agents.

Reshaping compositions, methods or processes, and kits-of-part reshape keratin fibers. The reshaping composition is a non-reducing, non-oxidizing composition for keratin fibers having a pH in the range of 7 to 12, and comprising a) one or more organic alkalizing agents having a pK.sub.a of less than 9.0, b) one or more lipophilic compounds being liquid at 25° C. and atmospheric pressure, at a total concentration in the range of 10% to 80% by weight, calculated to a total weight of the composition, c) one or more surfactants, and d) one or more thickening agents.

The disclosure relates to compositions comprising crosslinked hyaluronic acid physically mixed with collagen. Also contemplated are methods of improving an aesthetic quality of an anatomic feature of a human being.

Aqueous mixtures can include cellulose nanocrystals and sulfonated polyester, where a glass transition temperature (T.sub.g) of the sulfonated polyester is greater than 25° C. In some instances, exemplary aqueous mixtures also include one or more additives, such as pigment. Exemplary aqueous mixtures can be applied as a film that is typically hydrophobic and resilient against water at room temperature. Upon application of warm water, such as at temperatures of from about 30° C. to about 60° C., the film can be removed with no or limited abrasion and/or with no or little removal oils.

To provide a water in oil type emulsion cosmetic capable of obtaining a smooth and fresh sensation of use, and has superior emulsion stability. A water in oil type emulsion cosmetic contains (A) cetyl PEG/PPG 10-1 dimethicone; (B) silicone wax; (C) polyethylene glycol; and (D) a polar oil.

The present invention provides a solid composition containing an amorphous poorly water-soluble material, and a method for producing the same. The solid composition of the present invention is a solid composition containing an amorphous poorly water-soluble material (1a), hydroxypropylmethyl cellulose (2), and one or more types of water-soluble polysaccharides (3) other than hydroxypropylmethyl cellulose, and is characterized in that an XRD analysis value of the solid composition is 4.0% or less.

The present disclosure provides solid molded formulations comprising an emulsion gel comprising a gel matrix, water and lipophilic droplets comprising one or more emulsifiers and lipophilic material, the lipophilic droplets being dispersed within the gel matrix, wherein the gel matrix is formed of at least one gel forming material that is water insoluble at a temperature below 40° C.; the at least one gel forming material is present at a concentration higher than 1% by weight out of the total weight of the solid molded composition; the lipophilic material is present at a concentration of at least 5% by weight out of the total weight of the solid molded composition; at least 80% of the emulsifiers are solid at room temperature; and the said at least one gel forming material, one or more emulsifiers, lipophilic material and water provide together said solid molded composition with a discrete shape that is deformable upon shearing against a surface. Also disclosed are methods of producing the formulations.

The present disclosure provides solid molded formulations comprising an emulsion gel comprising a gel matrix, water and lipophilic droplets comprising one or more emulsifiers and lipophilic material, the lipophilic droplets being dispersed within the gel matrix, wherein the gel matrix is formed of at least one gel forming material that is water insoluble at a temperature below 40° C.; the at least one gel forming material is present at a concentration higher than 1% by weight out of the total weight of the solid molded composition; the lipophilic material is present at a concentration of at least 5% by weight out of the total weight of the solid molded composition; at least 80% of the emulsifiers are solid at room temperature; and the said at least one gel forming material, one or more emulsifiers, lipophilic material and water provide together said solid molded composition with a discrete shape that is deformable upon shearing against a surface. Also disclosed are methods of producing the formulations.